ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Alligator Bioscience Ab

Alligator Bioscience Ab (0RK9)

23.00
0.00
(0.00%)
Closed January 05 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
23.00
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
23.00 52 Week Range 23.00
Market Cap
Previous Close
23.00
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,512
Shares Outstanding
657,954,000
Dividend Yield
-
PE Ratio
-1.32
Earnings Per Share (EPS)
-0.38
Revenue
59.27M
Net Profit
-248.59M

About Alligator Bioscience Ab

Sector
Noncomml Resh Organizations
Industry
Noncomml Resh Organizations
Headquarters
Lund, Swe
Founded
-
Alligator Bioscience Ab is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker 0RK9. The last closing price for Alligator Bioscience Ab was SEK23. Over the last year, Alligator Bioscience Ab shares have traded in a share price range of SEK 23.00 to SEK 23.00.

Alligator Bioscience Ab currently has 657,954,000 shares outstanding. The market capitalization of Alligator Bioscience Ab is SEK15.13 billion. Alligator Bioscience Ab has a price to earnings ratio (PE ratio) of -1.32.

0RK9 Latest News

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10023232300DE
4002323231306223DE
1200232323951223DE
2600232323476123DE
5200232323359423DE
15600232323200623DE
26000232323201923DE

0RK9 - Frequently Asked Questions (FAQ)

What is the current Alligator Bioscience Ab share price?
The current share price of Alligator Bioscience Ab is SEK 23.00
How many Alligator Bioscience Ab shares are in issue?
Alligator Bioscience Ab has 657,954,000 shares in issue
What is the market cap of Alligator Bioscience Ab?
The market capitalisation of Alligator Bioscience Ab is SEK 15.13B
What is the 1 year trading range for Alligator Bioscience Ab share price?
Alligator Bioscience Ab has traded in the range of SEK 23.00 to SEK 23.00 during the past year
What is the PE ratio of Alligator Bioscience Ab?
The price to earnings ratio of Alligator Bioscience Ab is -1.32
What is the cash to sales ratio of Alligator Bioscience Ab?
The cash to sales ratio of Alligator Bioscience Ab is 5.55
What is the reporting currency for Alligator Bioscience Ab?
Alligator Bioscience Ab reports financial results in SEK
What is the latest annual turnover for Alligator Bioscience Ab?
The latest annual turnover of Alligator Bioscience Ab is SEK 59.27M
What is the latest annual profit for Alligator Bioscience Ab?
The latest annual profit of Alligator Bioscience Ab is SEK -248.59M
What is the registered address of Alligator Bioscience Ab?
The registered address for Alligator Bioscience Ab is MEDICON VILLAGE, SCHEELEVAGEN 2, LUND, 223 81
What is the Alligator Bioscience Ab website address?
The website address for Alligator Bioscience Ab is www.alligatorbioscience.se
Which industry sector does Alligator Bioscience Ab operate in?
Alligator Bioscience Ab operates in the NONCOMML RESH ORGANIZATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
71chris71 71chris71 6 minutes ago
The difference between the stocks that have come back to life and wcvc is only one ... Nixon has no intention of going public again
barnyarddog barnyarddog 6 minutes ago
About us


Kneron, a leading provider of edge AI solutions, was founded in 2015 at San Diego, US. It is dedicated to design and development of integrated software and hardware edge AI solutions. Barely two years old, Kneron already has partners and customers around
SPKL
Green Leaf Smoker Green Leaf Smoker 7 minutes ago
Yep thanks for verifying for all as past weeks trading was a reflection of the year 2024' "Pathetic"
Today we have more of the same, next year will have more of the same
Merry Go Round of NOTHING

💩The NOTHING to see here 💩💩💩 TRAIN is truly
MJNA
Monksdream Monksdream 7 minutes ago
Spectral AI, Inc. is a predictive artificial intelligence company. It focuses on medical diagnostics for faster and more accurate treatment decisions in wound care for burn, DFU, and future clinical applications. Its DeepView platform is a predictive diagnostic device that offers clinicians an objec
MDAI
fuagf fuagf 7 minutes ago
It clearly puts both best and worst of our cultures.
manibiotech manibiotech 8 minutes ago
Yep and then alarm clock rings 
Tring Tring
And then you wake up 
Which has been happening for 10 years 
NWBO
Seminole Red Seminole Red 8 minutes ago
Schumer Offers Up Explanation For His Party’s 2024 Drubbing: Voters ‘Didn’t Realize How Much’ Dems Had Done For Them

https://www.msn.com/en-us/news/politics/schumer-offers-up-explanation-for-his-party-s-2024-drubbing-voters-didn-t-realize-how-much-dems-had-done-for-them/ar-AA1wZOOr?oc
ThSeeker ThSeeker 9 minutes ago
From LinkedIn - “ - We rebranded the company and are excited to launch a new investor deck and website in Q1’25”
“As we close out 2024, we are reflecting on what has been a transformative finish to the year for Alset AI Ventures (TSX-V: GPUS), as we achieved significant milestones that positi
GPUS
Guido2 Guido2 9 minutes ago
One possible scenario:

If government were allowed to exercise the warrants, it could acquire roughly 7.26 billion shares of Fannie Mae and Freddie Mac for a total cost of roughly $72,600. That's SEVENTY TWO THOUSAND SIX HUNDRED DOLLARS.

NOT BILLIONS!
NOT MILLION
FNMA
pauljon4 pauljon4 10 minutes ago
Thanks Nats. It just seems like the warrants are a remedy for a condition which no longer exists. But, then again this entire conservatorship is a 16+ year long cluster F intent on screwing over everyday citizens.
FNMA
Red Cloud Red Cloud 10 minutes ago
Thanks so much for your response

I'll look for the text of those Warrant Agreements
FNMA
fuagf fuagf 10 minutes ago
Flip flop artist Trump is a flip, and sadly as president again will most likely be a flop.

https://www.usnews.com/object/image/00000194-1e6c-d7ea-a1d5-5fee8e950000/20241231ednac-a.jpg?update-time=1735677640116&size=responsiveGallery
barnyarddog barnyarddog 10 minutes ago
. NRx Pharmaceuticals is led by executives who have held leadership roles at Lilly, Pfizer, and Novartis as well as major investment banking institutions.



https://www.linkedin.com/company/nrx-pharma/
NRXP
Debunkinator Debunkinator 10 minutes ago
Short sellers down $180.9B in 2024 mark-to-market losses as Wall Street soars
LMAO--$$$$ Weeeeeeeeeeeeeeeeeeeeeeeee
ASII
attilathehunt attilathehunt 10 minutes ago
Somewhere in Bethesda....


Ring-a-ding-a-ring...

LP: Hello, this is Linda.

RD: Good morning Linda. This is Rob( Rob Davis, CEO of Merck)...

LP: Oh, hi Rob! I was expecting your call as soon as we received approval from the MHRA.
DJT NWBO
JR30 JR30 11 minutes ago
Shorty still crying when the SP is doing well.
VERB
dstock07734 dstock07734 11 minutes ago
I thought about the same thing. The only difference is that in my version Merck is the one who does the BLA submission to FDA. Just like what happened to the Daiichi's ADC. Here is the trial with Merck as collaborator. In October 2023, Merck and Daiichi struck the deal on three ADCs including the pl
NWBO
GetSeriousOK GetSeriousOK 11 minutes ago
OTC is entering a golden age in 2024 - Chartmaster.
OTC is entering a golden age in 2023 - Chartmaster.
OTC is entering a golden age in 2022 - Chartmaster.
I'm a genius and a millionaire - Chartmaster.

You know what they call that guy on every other board, don't y
BIEL
Monksdream Monksdream 12 minutes ago
HUH! Who wants to bet AAPL doesn’t make another new high in 2025
https://investorshub.advfn.com/uimage/uploads/2025/1/5/fngepIMG_4473.gif
AAPL
Involuntary-Recluse Involuntary-Recluse 12 minutes ago
Lmao, if only it worked that way T 😂
zab zab 13 minutes ago
I remember the real estate deferral tax deduction. I know I did not say it correctly,  but there is nothing better than claiming tax deduction on losses or gains in the future,  and using it to shield income. 
Hopeforthefuture3 Hopeforthefuture3 14 minutes ago
Eagle, imo good comparison in your post. One other item is that Kazia with paxalisib is part of the gbm AGILE program. As part of this they do have a patient level data control group. The program has 5 companies testing 5 different treatments and 1 soc control group to use as comparison with patient
NWBO
Zorax Zorax 15 minutes ago
Stupid Gets what Stupid Dose

Kind of ironic isn't it, using the wrong word about stupidity? lmao.

But then again, this just shows the tower of stupidity of trolls. I'd say the first 78 floors are empty of intelligence and the final 22 floors are just pure evil.
TURCH TURCH 17 minutes ago
Im ready for your long term play find it 😁


Regards 

Your Recent History

Delayed Upgrade Clock